Skip to main content
See every side of every news story
Published • loading... • Updated

Menopause drug made in Canada won't be available to Canadians, but still sold in U.S.

Pfizer said commercial pressures made the menopause drug unsustainable as Health Canada assesses shortages and physicians warn patients may face treatment changes.

  • Pfizer announced on Thursday it will discontinue Premarin vaginal cream and oral tablets in Canada, citing commercial unsustainability. The cream is pulled immediately while tablets remain available until next June.
  • Manufacturing costs and the pricing environment drove the decision, according to Pfizer Canada spokesperson Sophie Morin. The active ingredient is produced in Brandon, Manitoba, yet the medication remains available in the United States.
  • Menopause specialist Dr. Michelle Jacobson criticized the move, noting Canadians lose access to a homegrown product. Gynecologist Dr. Jen Gunter highlighted the price disparity: Premarin costs around $50 in Canada versus $400 to $500 in the United States.
  • Physicians warn that switching treatments may trigger rebound symptoms or complications like urinary tract infections. Provinces including Ontario are reviewing alternatives such as Estragyn to ensure continued access to hormone therapy.
  • A spokesperson for federal Health Minister Marjorie Michel said Health Canada is assessing the discontinuation's impact on supply. The decision coincides with a 228-per-cent increase in hormone-replacement therapy claims among women aged 45 to 54, per Manulife Canada.
Insights by Ground AI

31 Articles

The Toronto StarThe Toronto Star
+4 Reposted by 4 other sources
Lean Left

Menopause drug made in Canada won’t be available to Canadians, but still sold in U.S.

TORONTO - Canadian women will no longer have access to a menopause drug that is made in Canada, even though the drugmaker plans to continue producing it for patients in

·Toronto, Canada
Read Full Article
Winnipeg Free PressWinnipeg Free Press
+23 Reposted by 23 other sources
Center

Menopause drug made in Canada won't be available to Canadians, but still sold in U.S.

TORONTO - Canadian women will no longer have access to a menopause drug that is made in Canada, even though the drugmaker plans to continue producing it for patients in the United States.

·Winnipeg, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources lean Left
63% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Globe & Mail broke the news in Toronto, Canada on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal